ISSN Print 2713-2757
ISSN Online 2713-2765
SCIENTIFIC AND PRACTICAL REVIEWED JOURNAL OF FMBA OF RUSSIA
REVIEW
Cardiovascular comorbidity in patients with nonalcoholic fatty liver disease
About authors
1 Volgograd Medical Clinical Center of FMBA, Volgograd, Russia
2 Volgograd State Medical University, Volgograd, Russia
Correspondence should be addressed: Elena E. Gorbacheva
Kim, d. 24, k. 125, Volgograd, 400001, Russia; ur.xednay@1ilsak
About paper
Author contribution: Ledovskaya TI — conceived the idea, performed data analysis and interpretation; Statsenko ME, Turkina SV — formulated the problem and organized the study; Konyakhina TA — performed literature analysis and research conceptualization; Yusupov KS — searched the literature and wrote the manuscript; Gorbacheva EE — performed data analysis and interpretation.
Received: 2021-12-07
Accepted: 2021-12-20
Published online: 2021-12-22
|
Fig. Possible mechanisms underlying cardiovascular complications in patients with NAFLD. PAI-1 — plasminogen activator inhibitor-1; TGFβ — transforming growth factor β; IL6 — interleukin 6; IR — insulin resistance; FFA — free fatty acids; LV — left ventricle; VLDL_C — very-low-density lipoprotein cholesterol, HDL_C — high-density lipoprotein cholesterol, CRP — С-reactive protein
